| Serial Number | 79396229 |
| Word Mark | R |
| Filing Date | Friday, April 12, 2024 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Tuesday, November 5, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Medical, biological, pharmaceutical and veterinary preparations; medical, biological, pharmaceutical and veterinary preparations for preventing and treating infectious diseases, medical disorders, and diseases; medical, biological, pharmaceutical and veterinary preparations for preventing and treating infections such as viral, bacterial and yeast infections; medical, biological, pharmaceutical and veterinary preparations for preventing and treating cancer, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines; sanitary preparations for medical purposes; dietary supplements and dietetic preparations; dietetic substances adapted for medical use; diagnostic preparations for medical purposes; chemical diagnostic reagents for medical use; clinical medical reagents. |
| Goods and Services | Biological research, clinical research and medical research; pharmaceutical research and development services; pharmaceutical products development; pharmaceutical product evaluation; research and development in the field of microorganisms and cells; research of pharmaceuticals; testing of pharmaceuticals; research relating to pharmaceuticals; development of gene-based medicines; drug discovery services; conducting clinical trials for pharmaceutical products; scientific laboratory services; laboratory research services relating to pharmaceuticals; scientific risk assessment; consultancy in the field of pharmaceutical research; services for assessing the efficiency of pharmaceuticals; toxicity testing for research purposes; toxicity analysis; information technology services for the pharmaceutical and healthcare industries; conducting early evaluations in the field of new pharmaceuticals; providing information about the results of clinical trials for pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; chemical research and analysis services; medical and pharmacological research services; scientific services and research relating thereto; scientific research for medical purposes; scientific research for medical purposes in the area of diseases; conducting clinical trials; genetic research; genetic mapping for scientific purposes; DNA screening for scientific research purposes; providing scientific information in the field of medical disorders and their treatment; technical research in the field of pharmaceutical studies; veterinary research; design and development of computer software relating to the medical field; design and development of computer software relating to healthcare; computer programming in the medical field; scientific computer programming services; providing temporary use of non-downloadable software for capturing, storing, processing, evaluating and reproducing medical and pharmaceutical data; providing artificial intelligence computer programs on data networks; platforms for artificial intelligence as software as a service (SaaS); software as a service (SaaS) featuring computer software platforms for artificial intelligence; software as a service (SaaS) services; software as a service (SaaS) featuring artificial intelligence software; software as a service (SaaS) featuring artificial intelligence software for healthcare; software as a service (SaaS) featuring artificial intelligence software for analysis; software as a service (SaaS) featuring machine learning software for healthcare; software as a service (SaaS) featuring health monitoring software; software as a service (SaaS) featuring software relating to the medical field; software as a service (SaaS) featuring bioinformatics software; artificial intelligence consultancy; research in the field of artificial intelligence. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 23, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 23, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Rejuvenate Biomed NV |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 98 - Unknown |
| Address | BE |
| Party Name | Rejuvenate Biomed NV |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 32 - NOT AVAILABLE |
| Address | BE |
| Event Date | Event Description |
| Thursday, May 23, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Monday, June 3, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, October 25, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, October 29, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, June 3, 2024 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, October 30, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, November 5, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, November 8, 2024 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Saturday, November 23, 2024 | REFUSAL PROCESSED BY IB |
| Tuesday, November 5, 2024 | REFUSAL PROCESSED BY MPU |